NR2C2AP and rectum adenocarcinoma: TRA16 was significantly upregulated in 13 cancer types, including adrenocortical carcinoma (ACC), cervical squamous cell carcinoma (CESC), colon adenocarcinoma (COAD), diffuse large B-cell lymphoma (DLBC), glioblastoma multiforme (GBM), kidney renal papillary cell carcinoma (KIRP), lower-grade glioma (LGG), liver hepatocellular carcinoma (LIHC), lung squamous cell carcinoma (LUSC), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), testicular germ cell tumors (TGCT), and thymoma (THYM).